In the news today there have been reports that laquinimod, a new drug developed to treat multiple sclerosis (MS), has performed well in an early (Phase IIb) (1). An MS patient's immune system attacks their central nervous system, leading to impaired communication in the nervous system and finally to physical and cognitive disability. A key … Continue reading How mice helped develop a new drug for MS